Ozempic, food and drug administration

Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults ...
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication ... Zepbound’s new indication highlights its broader therapeutic potential.
Researchers say with weight loss, people reduce fat tissue inside their neck and throat, which can help keep airways open and make it easier to breathe while they sleep.